Si Bone Operating Income Over Time
| SIBN Stock | USD 15.29 0.33 2.11% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Si Bone Performance and Si Bone Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could SIBN diversify its offerings? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Si Bone data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.51) | Revenue Per Share | Quarterly Revenue Growth 0.206 | Return On Assets | Return On Equity |
Si Bone's market price often diverges from its book value, the accounting figure shown on SIBN's balance sheet. Smart investors calculate Si Bone's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Si Bone's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare Si Bone and related stocks such as Orthofix Medical, Pacific Biosciences, and Clearpoint Neuro Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OFIX | 20.9 M | 32.5 M | 89 M | (5.1 M) | 17.1 M | 9.3 M | 21.1 M | 40.8 M | 30.1 M | (18.8 M) | (6.3 M) | (8.3 M) | (13.3 M) | (139.1 M) | (84.6 M) | (76.2 M) | (72.3 M) |
| PACB | (23.4 M) | (109.8 M) | (94.3 M) | (77.5 M) | (62.9 M) | (29.1 M) | (71.2 M) | (89.8 M) | (101 M) | (100.5 M) | (104.4 M) | (210.4 M) | (307.2 M) | (334.5 M) | (474.3 M) | (557.6 M) | (529.7 M) |
| CLPT | (9.5 M) | (5.9 M) | (3.1 M) | (7.5 M) | (5.3 M) | (9 M) | (7.5 M) | (6.3 M) | (5.2 M) | (4.6 M) | (6.2 M) | (13.4 M) | (16.3 M) | (22.4 M) | (19.7 M) | (17.8 M) | (16.9 M) |
| BFLY | (53.1 M) | (53.1 M) | (53.1 M) | (53.1 M) | (53.1 M) | (53.1 M) | (53.1 M) | (53.1 M) | (53.1 M) | (102.3 M) | (161.6 M) | (192.7 M) | (193 M) | (145.6 M) | (74.4 M) | (67 M) | (70.3 M) |
| INNV | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.5 M) | (5.8 M) | (5.1 M) | 39.7 M | 50.9 M | 74.8 M | (4.4 M) | (49.4 M) | (23.2 M) | (29.8 M) | (26.8 M) | (25.4 M) |
| AIRS | 663 K | 663 K | 663 K | 663 K | 663 K | 663 K | 663 K | 663 K | 663 K | 663 K | 10 M | 15.8 M | (4.5 M) | 9.5 M | (1.8 M) | (1.6 M) | (1.6 M) |
| AVNS | 207.9 M | 207.9 M | 226.5 M | 222.9 M | 311.5 M | 154.8 M | (69.4 M) | (16 M) | 34.9 M | (5.4 M) | 70.9 M | 86.8 M | 41.9 M | 65 M | 40 M | 36 M | 34.2 M |
| AVXL | (14.5 K) | (4.3 M) | (2.1 M) | (3 M) | (7.1 M) | (15.6 M) | (15.5 M) | (19.2 M) | (28.8 M) | (31.1 M) | (41.9 M) | (51 M) | (47.5 M) | (52.9 M) | (51.4 M) | (46.3 M) | (44 M) |
| AQST | (7.8 M) | (847 K) | (847 K) | (847 K) | (847 K) | (847 K) | (847 K) | (113 K) | (48.9 M) | (52.7 M) | (42.9 M) | (34.7 M) | (42.1 M) | (15.1 M) | (30.8 M) | (27.7 M) | (29.1 M) |
| VREX | 168.8 M | 168.8 M | 168.8 M | 176 M | 127.5 M | 109.1 M | 83.7 M | 44.5 M | 8.2 M | (33.7 M) | 74.1 M | 88.2 M | 77.1 M | 32.1 M | (27.8 M) | (25 M) | (23.8 M) |
Si Bone and related stocks such as Orthofix Medical, Pacific Biosciences, and Clearpoint Neuro Operating Income description
Operating Income is the amount of profit realized from Si Bone operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Si Bone is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Si Bone | SIBN |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 471 El Camino |
| Exchange | NASDAQ Exchange |
USD 15.29
Check out Si Bone Performance and Si Bone Correlation. To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Si Bone technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.